<DOC>
	<DOCNO>NCT02894164</DOCNO>
	<brief_summary>This cohort study patient survive Acute Kidney Injury ( AKI ) intensive care unit ( ICU ) admission recall 3-6 month renal function test perform . The purpose study describe renal function AKI survivor follow . Additional aim determine well admission value renal function marker perform predictor renal function follow-up whether estimate renal function follow-up differ depend renal function marker use .</brief_summary>
	<brief_title>Evaluating Role Cystatin C Creatinine Markers Renal Recovery Critically Ill Patients After Acute Kidney Injury</brief_title>
	<detailed_description>Type study : Cohort study prospectively collect clinical data cross-matched local &amp; national database . Source population : Patients suffer AKI mixed intensive care unit , Karolinska University Hospital , Solna . Setting : Single centre , Central Intensive Care unit ( CIVA ) Karolinska University hospital , Solna Stockholm September 2008 May 2011 . Inclusion Criteria : All adult patient AKI ( accord RIFLE criterion ) survive 3 month follow-up . Admission time period study staff post . Exclusion : Children ( patient 18 year ) Patients refuse consent unable give consent . Admission time study staff work . Death ICU admission first 3 month admission . Exposure : AKI ICU grade AKI accord RIFLE criterion . Intervention : none Outcome : Renal function 3 month ICU discharge accord creatinine Cystatin C measurement . Parameters : Co-morbidities , ICU diagnose , disease severity score , daily physiological laboratory parameter , medication administer , intervention ( Renal replacement therapy ) RRT , mechanical intervention , inotropes , surgery . Data crossmatched national registry include Swedish cause death register ( obtain date death ) , Swedish renal register ( obtain detail patient receive chronic dialysis Chronic Kidney Disease ( CKD ) diagnose . Data also cross match large local ICU register ( Clinisoft ) obtain physiological parameter &amp; intervention detail . Clinisoft also use obtain risk death ICU patient AKI patient ( source population ) ( ethical approval Stockholm REPN 2010/1780-31-2 + 2001-408-32 ) . Aims : 1 . Describe incidence renal dysfunction ( GFR &lt; 60ml/min/173mÂ² ) 3-6 month follow-up AKI . According serum Cystatin C Creatinine value . 2 . Compare ability admission value Creatinine &amp; Cystatin C predict renal function follow-up three month AKI . 3 . Compare estimate Glomerular filtration rate ( GFR ) differ use creatinine Cystatin C value obtain follow-up . 4 . Produce predictive model use comorbidities admission data predict renal function 3-6 month AKI intensive care patient . Reference : RIFLE AKI classification . Bellomo R , Ronco C , Kellum JA , Mehta RL , Palevsky P , ADQI workgroup Acute renal failure - definition , outcome measure , animal model , fluid therapy information technology need : Second International Consensus Conference Acute Dialysis Quality Initiative ( ADQI ) Group . Crit Care . 2004 ; 8 : R204-R212 . doi : 10.1186/cc2872 .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Cystatins</mesh_term>
	<criteria>All adult patient AKI ( accord RIFLE criterion ) survive ICU stay 3 month followup . Admitted time period study staff post . Children ( patient 18 year ) Patients refuse consent unable give consent . Admission time study staff work . Death ICU admission first 3 month admission .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>